TABLE 2

Treatment Before 18F-FDG and 68Ga-DOTATATE PET/CT

Treatmentn
Surgery21 (20.2%)
Active surveillance20 (19.2%)
Long-acting SSA13 (12.5%)
None12 (11.5%)
CMT11 (10.6%)
Surgery, CMT10 (9.6%)
Further diagnostic procedure5 (4.8%)
Surgery, interferon4 (3.8%)
Surgery, 90Y, SSA4 (3.8%)
PRRT1 (1.0%)
Surgery, CMT, SSA, TACE, LDT1 (1.0%)
Surgery, radiofrequency ablation1 (1.0%)
LDT1 (1.0%)
  • SSA = somatostatin analogs; CMT = chemotherapy; 90Y = 90Y-DOTATATE therapy; TACE = transcatheter arterial chemoembolization; LDT = liver-directed therapy.